FR4499M - - Google Patents

Info

Publication number
FR4499M
FR4499M FR24367A FR24367A FR4499M FR 4499 M FR4499 M FR 4499M FR 24367 A FR24367 A FR 24367A FR 24367 A FR24367 A FR 24367A FR 4499 M FR4499 M FR 4499M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR24367A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR4499M publication Critical patent/FR4499M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR24367A 1964-04-16 1965-07-12 Expired FR4499M (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US360441A US3354173A (en) 1964-04-16 1964-04-16 Imidazole carboxylates

Publications (1)

Publication Number Publication Date
FR4499M true FR4499M (enExample) 1966-10-10

Family

ID=23417963

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1604115D Expired FR1604115A (en) 1964-04-16 1965-04-15 Imidazole esters hypnotics anticonvulsants sedatives
FR24367A Expired FR4499M (enExample) 1964-04-16 1965-07-12

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR1604115D Expired FR1604115A (en) 1964-04-16 1965-04-15 Imidazole esters hypnotics anticonvulsants sedatives

Country Status (6)

Country Link
US (1) US3354173A (enExample)
BE (1) BE662474A (enExample)
DE (1) DE1545988B2 (enExample)
FR (2) FR1604115A (enExample)
GB (1) GB1064531A (enExample)
SE (1) SE327708B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1475271A (en) * 1975-04-30 1977-06-01 Pfizer Ltd 1-aryl-2-1-imidazolyl-alkyl ethers and thioethers and their use as antifungal agents
DE2732531A1 (de) * 1977-07-19 1979-02-01 Hoechst Ag Imidazolcarbonsaeuren und deren derivate
JPS54148788A (en) * 1978-05-15 1979-11-21 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative and its preparation
GR64915B (en) * 1978-09-14 1980-06-09 Janssen Pharmaceutica Nv Improved etomidate-containing compositions
JPS5671073A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd Imidazole derivative
US4770689A (en) * 1986-03-10 1988-09-13 Janssen Pharmaceutica N.V. Herbicidal imidazole-5-carboxylic acid derivatives
GB8631020D0 (en) * 1986-12-30 1987-02-04 Janssen Pharmaceutica Nv 1-methyl-1h-imidazole-5-carboxylic acid derivatives
US6878735B2 (en) * 2002-05-31 2005-04-12 Board Of Trustees Of Michigan State University Multi-substituted imidazolines and method of use thereof
JPWO2008136428A1 (ja) * 2007-04-27 2010-07-29 武田薬品工業株式会社 含窒素5員複素環化合物
AU2013242865B2 (en) * 2008-03-31 2016-05-26 The General Hospital Corporation Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
RU2540116C2 (ru) * 2008-03-31 2015-02-10 Дзе Дженерал Хоспитал Корпорейшн Аналоги этомидата с улучшенными фармакокинетическими и фармакодинамическими свойствами
WO2011005969A2 (en) 2009-07-10 2011-01-13 The General Hospital Corporation Etomidate analogues that do not inhibit adrenocortical steroid synthesis
CN104168899B (zh) 2012-01-13 2017-04-05 通用医疗公司 麻醉剂化合物及其相关的使用方法
CN103739553B (zh) * 2013-12-23 2014-11-12 四川大学华西医院 含有醚侧链的n-取代咪唑羧酸酯手性化合物、制备方法和用途
CN109776512A (zh) * 2018-01-30 2019-05-21 成都安诺晨创医药科技有限公司 一种n-取代咪唑甲酸酯类衍生物及其用途
CN112375039B (zh) * 2020-11-20 2022-03-08 燃点(南京)生物医药科技有限公司 (r)-(+)-1-(1-苯乙基)-2-巯基咪唑-5-羧酸乙酯新晶型a及制备方法
CN113563266A (zh) * 2021-07-28 2021-10-29 江西汇和化工有限公司 一种连续化合成咪鲜胺及其原药中间酰化物的工艺
CN114292236A (zh) * 2021-12-24 2022-04-08 江苏慈星药业有限公司 一种依托咪酯中间体的制备方法
WO2025195256A1 (zh) * 2024-03-22 2025-09-25 四川科伦药物研究院有限公司 羧酸酯类化合物及其制备方法和用途
CN119707844B (zh) * 2024-12-18 2025-09-09 胜利油田华滨化工有限责任公司 一种高效原油脱硫剂及其合成方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1184709A (fr) * 1957-09-21 1959-07-24 Cfmc Nouveaux dérivés imidazoliques, utilisables comme agents de protection contre les rayons ultra-violets et leurs procédés de fabrication

Also Published As

Publication number Publication date
US3354173A (en) 1967-11-21
DE1545988B2 (de) 1976-01-29
SE327708B (enExample) 1970-08-31
DE1545988A1 (de) 1970-01-29
BE662474A (enExample) 1965-10-14
GB1064531A (en) 1967-04-05
FR1604115A (en) 1971-07-12

Similar Documents

Publication Publication Date Title
AU442366B2 (enExample)
BE651000A (enExample)
BE658832A (enExample)
BE642104A (enExample)
BE642458A (enExample)
BE642974A (enExample)
BE642588A (enExample)
BE47396A (enExample)
BE628611A (enExample)
BE642367A (enExample)
BE627931A (enExample)
BE483969A (enExample)
BE657993A (enExample)
BE613833A (enExample)
BE642735A (enExample)
BE642437A (enExample)
BE661239A (enExample)
BE658230A (enExample)
BE657957A (enExample)
BE518974A (enExample)
BE637777A (enExample)
SE327708B (enExample)
BE627057A (enExample)
BE658563A (enExample)
BE642770A (enExample)